MARKET

SPRO

SPRO

Spero Therapeuti
NASDAQ
2.600
+0.090
+3.59%
Closed 19:43 01/07 EST
OPEN
2.510
PREV CLOSE
2.510
HIGH
2.655
LOW
2.490
VOLUME
322.20K
TURNOVER
0
52 WEEK HIGH
3.220
52 WEEK LOW
0.5052
MARKET CAP
146.48M
P/E (TTM)
-3.2709
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SPRO last week (1229-0102)?
Weekly Report · 3d ago
Weekly Report: what happened at SPRO last week (1222-1226)?
Weekly Report · 12/29/2025 09:47
Weekly Report: what happened at SPRO last week (1215-1219)?
Weekly Report · 12/22/2025 09:46
GSK Resubmits NDA, Triggering Milestone for Spero Therapeutics
TipRanks · 12/19/2025 13:48
Spero Therapeutics to Receive $25 Million Milestone Payment Following Tebipenem HBr NDA Resubmission by GSK
Reuters · 12/19/2025 13:26
Spero announces GSK filed NDA resubmission to FDA for tebipenem HBr
TipRanks · 12/19/2025 13:17
Spero Therapeutics Announces GSK Files New Drug Application Resubmission to FDA For Tebipenem HBr To Treat Complicated Urinary Tract Infections
Benzinga · 12/19/2025 13:13
Spero Therapeutics Announces FDA Review of Tebipenem HBr NDA Resubmission
Reuters · 12/19/2025 13:00
More
About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Webull offers Spero Therapeutics Inc stock information, including NASDAQ: SPRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRO stock methods without spending real money on the virtual paper trading platform.